相关实验视频

Updated: May 16, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

在AI时代,探索化学空间,寻找"类似药物"的小分子

Aman Achuthan Kattuparambil¹, Dheeraj Kumar Chaurasia^2,3, Shashank Shekhar³

¹Department of Biological Sciences, BITS Pilani K K Birla Goa Campus, Zuarinagar, Goa, India.

Frontiers in molecular biosciences

|April 1, 2025

概括

人工智能 (AI) 正在彻底改变药物发现,将重点从传统的基于结构的药物设计 (SBDD) 转移到人工智能驱动的方法. 本综述强调了人工智能在小分子药物设计和理解目标相互作用方面的进展.

科学领域:

计算生物学计算生物学
药用化学医学化学
人工智能的人工智能

背景情况:

基于结构的药物设计 (SBDD) 是新疗法的传统研发方法.
人工智能 (AI) 的出现开始了药物设计研发的范式转变.
人工智能在生物学中的作用,特别是在药物发现方面,越来越被认可,这是2024年诺贝尔化学奖授予AlphaFold的证据.

研究的目的:

审查推进人工智能驱动的小分子药物设计的努力.
讨论了解药物设计中的"游戏规则"的改进,重点关注小分子-标相互作用.
为公众提供AI增强的工具和资源,用于药物发现.

主要方法:

小分子库的开发和描述.
创建一个基于公共知识的药物设计资源.
开发用于公众使用的选工具.
集成领域知识,以增强AI在药物设计中的利用.

主要成果:

展示人工智能在小分子药物设计方面的进展.
提供新的小分子库和基于知识的资源.
引入公开可用的选工具.
通过三个案例研究,展示领域知识对人工智能驱动药物设计的影响.

结论:

人工智能正在改变药物发现,提供超越传统SBDD的新范式.
综合领域知识显著提高了AI在药物设计中的有效性.
人工智能在药物设计中的未来范围为开发新疗法提供了巨大的潜力.

关键词:

这就是BIMP.人工智能的人工智能是人工智能.计算机辅助药物设计 (CADD)机器学习 (ML) 是指机器学习.小分子的小分子.

更多相关视频

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...